Type III Transforming Growth Factor beta Receptor in Coronary Vessel Development

冠状血管发育中的 III 型转化生长因子 β 受体

• 批准号: 7662025
• 负责人: Joey V. Barnett
• 金额: $ 2.96万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-02-01 至 2012-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7662025
• 关键词: Accounting; Address; Adult; Animals; Appearance; Basic Science; Blood Vessels; Cardiovascular Diseases; Cell Differentiation process; Cell Lineage; Cells; Cessation of life; Clinical; Coronary; Coronary Arteriosclerosis; Coronary Vessels; Data; Derivation procedure; Development; Disease; Drug Delivery Systems; Embryo; Endothelial Cells; Epicardium; Epithelial; Failure; Growth Factor Receptors; Human; In Vitro; Laboratories; Myocardium; Nature; Null Lymphocytes; Pathway interactions; Regulation; Role; Signal Pathway; Signal Transduction; Smooth Muscle; TGF beta type III receptor; Testing; Therapeutic; Transforming Growth Factors; United States; Venous; cell behavior; immortalized cell; in vivo; injured; insight; novel; programs; receptor; repaired; research study; vascular bed; vasculogenesis

DESCRIPTION (provided by applicant): Coronary artery disease accounts for 54% of all cardiovascular disease in the United States [1]. Understanding how coronary vessels develop is likely to uncover novel drug targets and therapeutic strategies useful in directing the repair or remodeling of coronary vessels in adults. Recent data from our laboratory has demonstrated that targeted deletion of the Type III Transforming Growth Factor 2 receptor (TGF2R3) results in embryonic death associated with failure of the formation or persistence of the coronary vessels while other vascular beds appear to develop normally. Experiments are proposed to identify how the loss of TGF2R3 results in the failure of coronary vessel development and to reveal the TGF2 signaling pathways that regulate epicardial cell differentiation. We will test 3 specific hypotheses. Hypothesis 1: TGF2R3 is required for proper epicardial differentiation. This will be tested by in vivo analysis of the epicardium and epicardial derivatives in wildtype, heterozygous Tgfbr3 null, and homozygous Tgfbr3 null animals. Hypothesis 2: TGF2R3 is required in the epicardium or myocardium for proper coronary vessel development. This will be tested by conditional deletion of Tgfbr3 in the epicardium and myocardium. Hypothesis 3: Specific TGF2 signaling pathways regulate epicardial cell differentiation. This will be tested in vitro in both explants and immortalized cells from wildtype, heterozygous Tgfbr3 null, and homozygous Tgfbr3 null animals The successful completion of the proposed experiments will yield significant insight into the role of Transforming Growth Factor 2 (TGF2) in coronary vessel development. The unique nature of the derivation of the coronary vessels and the significance of coronary vessel disease in humans makes the determination of the mechanisms behind TGF2R3 regulation of coronary vasculogenesis of high significance from both a basic science and clinical perspective.

描述（由申请人提供）：冠状动脉疾病占美国所有心血管疾病的54%[1]。了解冠状动脉血管如何发育可能会发现新的药物靶点和治疗策略，用于指导成人冠状动脉血管的修复或重塑。我们实验室的最新数据表明，靶向缺失III型转化生长因子2受体（TGF 2 R3）会导致与冠状血管形成或持续性失败相关的胚胎死亡，而其他血管床似乎正常发育。实验提出，以确定如何在冠状动脉血管的发展失败的结果的损失，并揭示TGF 2信号通路，调节心外膜细胞分化。我们将测试三个具体的假设。假设1：TGF 2 R3是心外膜分化所必需的。这将通过野生型、杂合Tgfbr 3缺失和纯合Tgfbr 3缺失动物的心外膜和心外膜衍生物的体内分析进行测试。假设2：心脏外膜或心肌中需要TGF 2 R3来进行适当的冠状动脉血管发育。这将通过心外膜和心肌中Tgfbr 3的条件性缺失进行测试。假设3：特定的TGF-2信号通路调节心外膜细胞分化。这将在来自野生型、杂合Tgfbr 3缺失和纯合Tgfbr 3缺失动物的外植体和永生化细胞中进行体外测试。所提出的实验的成功完成将产生对转化生长因子2（TGF 2）在冠状血管发育中的作用的显著洞察。冠状动脉血管起源的独特性质和冠状动脉疾病在人类中的重要性使得从基础科学和临床角度确定TGF 2 R3调节冠状动脉血管发生的机制具有重要意义。